Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Thymoma and thymic carcinoma
Results 1-17 of 17 for your search:
Start Over
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
Vaccine Therapy and Iscomatrix with or without Cyclophosphamide and Celecoxib in Treating Patients with Thoracic Malignancies or Tumors That Have Spread to the Chest Cavity
Status: Temporarily closed
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0053, NCI-2014-02465, 140053, 348360, P131392, NCT02054104
Plicamycin in Treating Patients with Primary Thoracic Malignancies or Carcinomas, Sarcomas, or Germ Cell Tumors with Pleuropulmonary Metastases
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16-C-0152, NCI-2016-01247, P152145, NCT02859415
PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: PEN-221-001, NCI-2017-00043, NCT02936323
Plicamycin in Treating Patients with Malignancies Involving the Lungs, Esophagus, or Pleura That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-C-0151, NCI-2013-01534, 120151, P12961, NCT01624090
Buparlisib in Treating Patients with Relapsed or Refractory Thymomas
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: IUCRO-0478, NCI-2014-01946, NCT02220855
Nintedanib and Prednisone in Reducing Radiation-Induced Pneumonitis in Patients with Thoracic Malignancies
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 14-167, NCI-2015-01232, NCT02496585
Pembrolizumab in Treating Patients with Rare Tumors That Cannot Be Removed by Surgery or are Metastatic
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2015-0948, NCI-2016-00545, NCT02721732
Ribociclib and Everolimus in Treating Patients with Advanced Well Differentiated Neuroendocrine Tumors of Foregut Origin
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 16-1535, NCI-2017-00449, NCT03070301
Avelumab in Treating Patients with Advanced Thymoma or Thymic Carcinoma That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 17-C-0066, NCI-2017-00530, P152483, NCT03076554
Heated Cisplatin following Surgery in Treating Younger Patients with Primary or Metastatic Pleural Malignancies
Status: Active
Phase: Phase I
Type: Treatment
Age: 3 to 21
Trial IDs: 2012-0657, NCI-2014-01101, NCI-2014-00510, NCT01998529
Veliparib, Capecitabine, and Temozolomide in Treating Patients with Advanced, Metastatic, and Recurrent Neuroendocrine Tumor That Cannot Be Removed by Surgery
Status: Not yet active
Phase: Phase I
Type: Treatment
Age: 19 and over
Trial IDs: VICC GI 14134, NCI-2016-01044, NCT02831179
Genetic Testing in Samples from Patients with Thoracic Malignancies and Determining Patient Eligibility to Participate in Clinical Trials
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 18 and over
Trial IDs: 06-C-0014, NCI-2013-02054, 060014, P6650, NCT00242723
Tissue Collection and Natural History Study of Patients with Non-small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, or Thymic Epithelial Tumors
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository
Age: Over 18
Trial IDs: 14-C-0105, NCI-2015-01304, 334365, P131444, NCT02146170
Proton Beam Radiation Therapy in Treating Patients with Recurrent Thoracic Cancer Who Have Received Prior Radiation Therapy
Status: Active
Phase: No phase specified
Type: Treatment
Age: 19 and older
Trial IDs: 9148, NCI-2014-01468, NCT02204761
Online Coping Skills Curriculum in Improving Quality of Life in Cancer Patients and Survivors with Chronic Pain
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00061381, NCI-2015-00756, NCT02465892
Start Over